Global Endometriosis Drugs Market 2016-2020

1
Global Endometriosis Drugs Market 2016-2020
Telephone [phone]Mail at
sales_at_researchbeam.com
(Type, Mode of action, Crop Type and Geography) -
Size, Share, Global Trends, Company Profiles,
Demand, Insights, Analysis, Research, Report,
Opportunities, Segmentation and Forecast, 2013 -
2020
Published on Oct 2014
2


Report Overview

• About the Endometriosis Market
• Endometriosis is a common health condition in
  women where the endometrial tissue, which is
  found in the lining of the uterus, appears and
  grows outside the uterine cavity. The endometrial
  tissue is shed from the body during menstruation.
  
• The tissue growing outside the uterine cavity is
  called endometrial implants. Endometriosis can
  also occur in the fallopian tubes, ovaries,
  pelvic cavity, vagina, cervix, and bladder. In
  rare cases, it has been reported in other parts
  of the body such as the lungs, brain, and skin.
  These implants are usually benign in nature.
  Women of reproductive age are often affected by
  this condition.
• Endometriosis often occurs due to retrograde
  menstruation, where the menstrual blood flows
  back into the pelvic cavity instead of leaving
  the body. This then adheres to the surface of the
  bladder, ovaries, or rectum and continues to grow
  or thicken over the course of each menstrual
  cycle.
• Analysts forecast the global endometriosis market
  to grow at a CAGR of 2.05 during the period
  2016-2020
• Strategic Focus Report _at_
• http//www.researchbeam.com/global-endometriosis-d
  rugs-2016-2020-market

3


Report Overview
Covered in this report The report covers the
present scenario and the growth prospects of the
global endometriosis market for 2016-2020. To
calculate the market size, the report considers
revenue generated from the sales of approved and
off-label branded and generic drugs used for the
treatment and prevention of endometriosis and
related pain. The report also considers the
revenues to be generated from the sales of drugs
that are expected to be launched into the market
along with the decline in revenues from the
patent expiries of the marketed drugs during the
forecast period. The market is divided into the
following segments based on geography
Americas APAC EMEA Key vendors AbbVie
AstraZeneca Bayer HealthCare Pfizer
4


Report Overview
Other prominent vendors Addex Therapeutics
Astellas Pharma Debiopharm ElexoPharm
Endoceutics Euroscreen Forendo Pharma
Isifer Kissei Pharmaceutical Neurocrine
Biosciences Nippon Shinyaku ObsEva
Orphagen Pharmaceuticals Philogen PregLem
Repros Therapeutics Roivant Sciences SK
Chemicals  
5


Report Ordering
Report Name Global Endometriosis Drugs Market
2016-2020
Product Price
User Price
Single User US 2500
Five User US 3000
Site User US 4000
Global User US 10000
To View Sample or Purchase Report
6



Contact Us
FOR MORE DETAILS
Visit us at
http//www.researchbeam.com/global-endometriosis-d
rugs-2016-2020-market
Stay With Us At
5933 NE Win Sivers Drive,205, Portland, OR
97220United States
TELEPHONE [phone] DIRECT 1 (503)
894-6022E-MAIL sales_at_researchbeam.com